Cost-Benefit Analysis of Novel Antiviral Ritonavir in the Active Duty U.S. Military Population.

Morrison Ponce, Daphne; Kitchen, Levi K; Devlin, John J

Morrison Ponce, Daphne; Kitchen, Levi K; Devlin, John J.

Morrison Ponce D; Department of Emergency Medicine, Naval Medicine Readiness and Training Command, Portsmouth, VA 23708, USA.
Kitchen LK; Department of Emergency Medicine, Naval Medicine Readiness and Training Command, Portsmouth, VA 23708, USA.
Devlin JJ; US Marine Forces Command, Norfolk, VA 23551, USA.

Mil Med ; 187(9-10): 274-275, 2022 08 25.

Article in English | MEDLINE | ID: covidwho-2018010

Subject(s)

Military Personnel; Antiviral Agents/therapeutic use; Cost-Benefit Analysis; Humans; Ritonavir/pharmacology; Ritonavir/therapeutic use; United States

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Military Personnel Limits: Humans Country/Region as subject: North America Language: English Journal: Mil Med Year: 2022 Document Type: Article Affiliation country: Milmed

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google